抗核抗体
生物
免疫学
B细胞
染色质
自身免疫
抗体
抗原
CD40
病毒学
红斑狼疮
自身免疫性疾病
病毒
白细胞介素21
系统性红斑狼疮
T细胞
重编程
分子生物学
发病机制
ZAP70型
抗原提呈细胞
作者
Shady Younis,Salvinaz Islam Moutusy,Sajede Rasouli,Shaghayegh Jahanbani,Mahesh Pandit,Xiaohao Wu,Suman Acharya,Orr Sharpe,Tilini U. Wijeratne,Marlayna L. Harris,Emily Yang,Yashaar Chaichian,Shima Parsafar,Matthew Baker,John B. Harley,Eric Meffre,Lawrence Steinman,Ann Marshak‐Rothstein,Judith A. James,Olivia M. Martinez
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2025-11-12
卷期号:17 (824): eady0210-eady0210
被引量:81
标识
DOI:10.1093/jimmun/vkag141.1301
摘要
Abstract Introduction Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by anti-nuclear antibodies (ANA). Epstein-Barr virus (EBV) infection has been epidemiologically associated with SLE, yet its role in pathogenesis remains incompletely defined. Methods We developed an EBV-specific single-cell RNA-sequencing platform and used it to sequence EBV-infected B cells directlry isolated form the patient. Using combined EBV-seq, CITE-seq, BCR-seq, and scRNA-seq, we sequenced the EBV genes, B cell receptor (BCR) repertoires, and transcriptomes of blood B cells from patients with SLE . Results We demonstrated that, in SLE, EBV+ B cells are predominantly CD27+CD21low memory B cells that are present at increased frequencies and express ZEB2, TBX21, and antigen presenting cell transcriptional pathways. Integrative analysis of chromatin immunoprecipitation sequencing (ChIP-seq), assay for transposase-accessible chromatin (ATAC-seq), and RNA Polymerase II occupancy data revealed EBNA2 binding at the transcriptional start sites and regulatory regions of CD27, ZEB2, and TBX21 (Tbet), as well as the antigen presenting cell genes demonstrated to be up-regulated in SLE EBV+ B cells. We expressed recombinant antibodies from SLE EBV+ B cells and demonstrated that they bind prototypical SLE nuclear autoantigens, whereas those from healthy individuals do not. We further found that SLE EBV+ B cells can serve as antigen presenting cells to activate T peripheral helper cells with concomitant activation of related EBV- anti-nuclear double negative 2 B cells and plasmablasts. Conclusion Our results provide a potential mechanistic basis for EBV being a driver of SLE through infecting and reprograming nuclear antigen reactive B cells to become activated antigen presenting cells with the potential to promote systemic disease-driving autoimmune responses. Funding Source Lupus Research Alliance Topic Categories Basic Autoimmunity (BA)
科研通智能强力驱动
Strongly Powered by AbleSci AI